Home Top News and Stories World News Headlines UK authorizes Merck and Ridgeback Biotherapeutics’ antiviral pill to treat Covid-19

UK authorizes Merck and Ridgeback Biotherapeutics’ antiviral pill to treat Covid-19

0
   

UK authorizes Merck and Ridgeback Biotherapeutics’ antiviral pill to treat Covid-19

The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness.

   

Follow us on Instagram

[instagram-feed]